Understanding how METTL5 affects liver cancer growth
Investigating METTL5-regulated translational changes in hepatocellular carcinoma
This study is looking at how a protein called METTL5 affects the way liver cancer cells grow and produce proteins, with the hope that understanding this could help develop new treatments for liver cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10871903 on NIH RePORTER |
What this research studies
This research investigates the role of METTL5, a specific methyltransferase, in the regulation of protein production in liver cancer cells. By examining how changes in ribosome composition and specific RNA modifications influence cancer cell behavior, the study aims to uncover mechanisms that support the rapid growth of hepatocellular carcinoma (HCC). The approach includes biochemical characterization and imaging techniques to analyze the effects of METTL5 on cell proliferation and translation processes. Patients may benefit from insights that could lead to new therapeutic strategies targeting these molecular pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hepatocellular carcinoma or those at high risk for developing liver cancer.
Not a fit: Patients with other types of cancer or those without liver disease may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatments that inhibit liver cancer growth by targeting the mechanisms regulated by METTL5.
How similar studies have performed: While the specific role of METTL5 in liver cancer is being explored, similar research has shown promise in understanding translational regulation in cancer, indicating potential for success.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Sepich, Caraline Lee — University of Chicago
- Study coordinator: Sepich, Caraline Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.